Versant Capital Management’s Cigna CI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $445K | Buy |
1,616
+102
| +7% | +$28.8K | 0.04% | 329 |
|
|
2026
Q1 | $404K | Buy |
1,514
+647
| +75% | +$179K | 0.04% | 336 |
|
|
2025
Q4 | $239K | Sell |
867
-564
| -39% | -$158K | 0.03% | 435 |
|
|
2025
Q3 | $412K | Sell |
1,431
-499
| -26% | -$148K | 0.06% | 246 |
|
|
2025
Q2 | $638K | Sell |
1,930
-36
| -2% | -$11.6K | 0.1% | 127 |
|
|
2025
Q1 | $647K | Buy |
1,966
+1,382
| +237% | +$416K | 0.11% | 115 |
|
|
2024
Q4 | $161K | Buy |
584
+352
| +152% | +$112K | 0.03% | 214 |
|
|
2024
Q3 | $80.4K | Buy |
232
+6
| +3% | +$2.06K | 0.02% | 295 |
|
|
2024
Q2 | $74.7K | Buy |
226
+12
| +6% | +$4.14K | 0.02% | 267 |
|
|
2024
Q1 | $77.7K | Hold |
214
| – | – | 0.02% | 223 |
|
|
2023
Q4 | $64.1K | Buy |
214
+3
| +1% | +$877 | 0.02% | 248 |
|
|
2023
Q3 | $60.4K | Hold |
211
| – | – | 0.02% | 241 |
|
|
2023
Q2 | $59.2K | Buy |
211
+7
| +3% | +$1.82K | 0.02% | 245 |
|
|
2023
Q1 | $52.1K | Hold |
204
| – | – | 0.02% | 251 |
|
|
2022
Q4 | $67.6K | Hold |
204
| – | – | 0.02% | 184 |
|
|
2022
Q3 | $57K | Hold |
204
| – | – | 0.02% | 194 |
|
|
2022
Q2 | $54K | Hold |
204
| – | – | 0.02% | 216 |
|
|
2022
Q1 | $49K | Sell |
204
-60
| -23% | -$14K | 0.02% | 262 |
|
|
2021
Q4 | $61K | Hold |
264
| – | – | 0.02% | 211 |
|
|
2021
Q3 | $53K | Hold |
264
| – | – | 0.02% | 223 |
|
|
2021
Q2 | $63K | Sell |
264
-48
| -15% | -$12K | 0.02% | 193 |
|
|
2021
Q1 | $75K | Hold |
312
| – | – | 0.03% | 180 |
|
|
2020
Q4 | $64K | Sell |
312
-182
| -37% | -$35.7K | 0.03% | 196 |
|
|
2020
Q3 | $83K | Sell |
494
-1
| -0.2% | -$176 | 0.04% | 150 |
|
|
2020
Q2 | $92K | Hold |
495
| – | – | 0.04% | 140 |
|
|
2020
Q1 | $87K | Sell |
495
-52
| -10% | -$10.1K | 0.05% | 133 |
|
|
2019
Q4 | $111K | Buy |
547
+408
| +294% | +$74.8K | 0.06% | 121 |
|
|
2019
Q3 | $21K | Sell |
139
-19
| -12% | -$3.09K | 0.01% | 442 |
|
|
2019
Q2 | $24K | Sell |
158
-3
| -2% | -$470 | 0.01% | 405 |
|
|
2019
Q1 | $25K | Sell |
161
-19
| -11% | -$3.47K | 0.01% | 503 |
|
|
2018
Q4 | $34K | Buy |
180
+76
| +73% | +$15.9K | 0.02% | 344 |
|
|
2018
Q3 | $21K | Buy |
104
+2
| +2% | +$371 | 0.01% | 603 |
|
|
2018
Q2 | $17K | Sell |
102
-2
| -2% | -$346 | 0.01% | 684 |
|
|
2018
Q1 | $17K | Sell |
104
-12
| -10% | -$2.33K | 0.01% | 689 |
|
|
2017
Q4 | $23K | Hold |
116
| – | – | 0.01% | 586 |
|
|
2017
Q3 | $21K | Sell |
116
-2
| -2% | -$356 | 0.01% | 561 |
|
|
2017
Q2 | $19K | Sell |
118
-23
| -16% | -$3.69K | 0.01% | 608 |
|
|
2017
Q1 | $20K | Hold |
141
| – | – | 0.01% | 576 |
|
|
2016
Q4 | $18K | Buy |
141
+3
| +2% | +$393 | 0.01% | 623 |
|
|
2016
Q3 | $17K | Buy |
138
+14
| +11% | +$1.83K | 0.01% | 620 |
|
|
2016
Q2 | $15K | Hold |
124
| – | – | 0.01% | 627 |
|
|
2016
Q1 | $17K | Sell |
124
-6
| -5% | -$824 | 0.01% | 574 |
|
|
2015
Q4 | $19K | Buy |
+130
| New | +$17.9K | 0.01% | 508 |
|
Other funds holding CI
LMFP
MIHAS
WAM
AAMU
CGH
JLBC
Versant Capital Management's CI Position: Q2 2026 in Review
Versant Capital Management increased its Cigna (CI) stake by 6.7% in Q2 2026, buying an estimated $28.8K and bringing the position to 1,616 shares worth $445K. The position accounts for 0.04% of the portfolio, ranked #329.
Versant Capital Management first reported a position in CI in Q4 2015 and has held it in 43 quarters since. The position peaked at $647K in Q1 2025. 476 funds tracked by Wall St. Rank hold CI as of Q2 2026.
- Versant Capital Management held 1,616 shares of Cigna worth $445K as of Q2 2026.
- Versant Capital Management bought 102 Cigna shares in Q2 2026, an estimated $28.8K.
- Cigna made up 0.04% of Versant Capital Management's portfolio in Q2 2026, its #329 holding.
- Versant Capital Management first reported a position in Cigna in Q4 2015 and has held it in 43 quarters since.
- Versant Capital Management's Cigna position peaked at $647K in Q1 2025.
- 476 funds tracked by Wall St. Rank held Cigna as of Q2 2026.
Based on Versant Capital Management's 13F filing for Q2 2026, filed 2 Jul 2026.